Private Market View

Biopolymer Technologies

Yekaterinburg, Russia · Founded 2012 · Privately Held (backing)

Last price · $/share
Implied valuation
Total raised
$17.8M
Last round

Key facts

  • It has raised $17.8M; the latest was Later Stage VC ($3.8M) in Jan 2025.
  • Notable investors include MassChallenge, European Union, GenerationS Accelerator, Government of Russia, Gregory Berenstein9 tracked in total.
  • Status: Privately Held (backing).
Free account
See the evidence behind this price
  • ·The complete investor list — 9 names
  • ·Watchlist + deal alerts for Biopolymer Technologies
  • ·The full record, as it builds
Create free account
No card required

Funding rounds

No rounds on record

No funding rounds for Biopolymer Technologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

About Biopolymer Technologies

Operator of an environmental biotechnology company intended to solve global environmental and climate change problems utilizing recyclates of agricultural waste. The company offers nanoscale organic polymer reverse-soluble particles that can possess surface-active properties, encapsulate any mineral and vegetable oils and fats, separate them from water or solid surfaces, and return to the technological cycle after separation, enabling businesses to get multi-purification from complex pollutants.

Sector
Materials and Resources
HQ
Yekaterinburg, Russia
Founded
2012
Employees
180
Ownership
Privately Held (backing)
PA Mark — not yet priced

Biopolymer Technologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.

Pro members can request priority coverage with a 48-hour turnaround.

Recorded secondary trades

No prints on record

No secondary trades in Biopolymer Technologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.

Pro members can request priority coverage with a 48-hour turnaround.

Institutional fund marks

No fund marks yet

No SEC-registered fund has reported a fair-value mark on Biopolymer Technologies in its N-PORT filings yet. We sweep new filings monthly.

Pro members can request priority coverage with a 48-hour turnaround.